These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8306452)

  • 21. Effects of simvastatin, a cholesterol synthesis inhibitor, on phosphatidylcholine synthesis in HepG2 cells.
    Yanagita T; Yamamoto K; Ishida S; Sonda K; Morito F; Saku K; Sakai T
    Clin Ther; 1994; 16(2):200-8. PubMed ID: 8062316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vastatins have a distinct effect on sterol synthesis and progesterone secretion in human granulosa cells in vitro.
    van Vliet AK; van Thiel GC; Naaktgeboren N; Cohen LH
    Biochim Biophys Acta; 1996 Jun; 1301(3):237-41. PubMed ID: 8664334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum pseudocholinesterase activity in rabbits fed simvastatin.
    Van Lith HA; Meijer GW; Haller M; Beynen AC
    Biochem Pharmacol; 1991 Feb; 41(3):460-1. PubMed ID: 1994903
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment.
    Miettinen TA; Gylling H;
    Clin Chim Acta; 2007 Apr; 379(1-2):53-8. PubMed ID: 17258182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men.
    Nissinen MJ; Miettinen TE; Gylling H; Miettinen TA
    Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):308-16. PubMed ID: 19695854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevation of plasma lathosterol, as an indicator of increased cholesterol synthesis, in preterm (23-32 weeks gestation) infants given Intralipid.
    Hamilton JJ; Phang M; Innis SM
    Pediatr Res; 1992 Feb; 31(2):186-92. PubMed ID: 1542550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastatin influences linoleic acid metabolism.
    van Doormaal JJ; Bos WJ; Muskiet FA; Doorenbos H
    Pharm Weekbl Sci; 1989 Aug; 11(4):134-5. PubMed ID: 2798037
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia.
    Zhao SP; Hollaar L; van 't Hooft FM; Smelt AH; Gevers Leuven JA; van der Laarse A
    Clin Chim Acta; 1991 Dec; 203(2-3):109-17. PubMed ID: 1777975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia].
    Aubert I; Emmerich J; Charpak Y; Chanu B; Dachet C; Herlich D; Besseau M; Rouffy J; Jacotot B
    Presse Med; 1988 May; 17(18):901-4. PubMed ID: 2968595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
    Mol MJ; Stuyt PM; Stalenhoef AF
    Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin.
    De Vries AC; Vermeer MA; Bredman JJ; Bär PR; Cohen LH
    Exp Eye Res; 1993 Apr; 56(4):393-9. PubMed ID: 8500554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins, cholesterol, and mevalonate pathways?
    Lewis LS
    Lancet; 1996 Feb; 347(9000):551. PubMed ID: 8596303
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells.
    Nagata Y; Hidaka Y; Ishida F; Kamei T
    Biochem Pharmacol; 1990 Aug; 40(4):843-50. PubMed ID: 2167097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
    van Deursen RT; Nieuwenhuijzen Kruseman AC; Degenaar CP; Wolffenbuttel BH
    Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2142-6. PubMed ID: 2247172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
    Ide H; Fujiya S; Aanuma Y; Agishi Y
    Clin Ther; 1990; 12(5):410-20. PubMed ID: 2268863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
    Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pravastatin and simvastatin differently inhibit cholesterol biosynthesis in human lens.
    de Vries AC; Vermeer MA; Bloemendal H; Cohen LH
    Invest Ophthalmol Vis Sci; 1993 Feb; 34(2):377-84. PubMed ID: 8440592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine.
    Vanhaecke J; Van Cleemput J; Van Lierde J; Daenen W; De Geest H
    Transplantation; 1994 Jul; 58(1):42-5. PubMed ID: 8036706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol synthesis inhibitors do not reduce Lp(a) levels in normocholesterolemic patients.
    Pazzucconi F; Franceschini G; Gianfranceschi G; Campagnoli G; Sirtori CR
    Pharmacol Res; 1996; 34(3-4):131-3. PubMed ID: 9051704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
    Darling GM; Johns JA; McCloud PI; Davis SR
    N Engl J Med; 1997 Aug; 337(9):595-601. PubMed ID: 9271481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.